PUBLICATION
A DUSP6 inhibitor suppresses inflammatory cardiac remodeling and improves heart function after myocardial infarction
- Authors
- Zhang, Z., Chen, Y., Zheng, L., Du, J., Wei, S., Zhu, X., Xiong, J.W.
- ID
- ZDB-PUB-221209-12
- Date
- 2023
- Source
- Disease models & mechanisms 16(5): (Journal)
- Registered Authors
- Xiong, Jing-Wei
- Keywords
- BCI, DUSP6, Inflammation, Macrophages, Myocardial infarction, PLGA
- MeSH Terms
-
- Animals
- Dual Specificity Phosphatase 6
- Fibrosis
- Myocardial Infarction*/complications
- Myocardial Infarction*/drug therapy
- Rats
- Ventricular Remodeling
- PubMed
- 36478044 Full text @ Dis. Model. Mech.
Citation
Zhang, Z., Chen, Y., Zheng, L., Du, J., Wei, S., Zhu, X., Xiong, J.W. (2023) A DUSP6 inhibitor suppresses inflammatory cardiac remodeling and improves heart function after myocardial infarction. Disease models & mechanisms. 16(5):.
Abstract
Acute myocardial infarction (MI) results in loss of cardiomyocytes and abnormal cardiac remodeling with severe inflammation and fibrosis. However, how cardiac repair can be achieved by timely resolution of inflammation and cardiac fibrosis remains incompletely understood. Our previous findings have shown that dual-specificity phosphatase 6 (DUSP6) is a regeneration repressor from zebrafish to rats. In this study, we found that intravenous administration of the DUSP6 inhibitor (E)-2-benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one (BCI) improved heart function and reduced cardiac fibrosis in MI rats. Mechanistic analysis revealed that BCI attenuated macrophage inflammation through NF-κB and p38 signaling, independent of DUSP6 inhibition, leading to the downregulation of various cytokines and chemokines. In addition, BCI suppressed differentiation-related signaling pathways and decreased bone-marrow cell differentiation into macrophages through inhibiting DUSP6. Furthermore, intramyocardial injection of poly (D, L-lactic-co-glycolic acid)-loaded BCI after MI had a notable effect on cardiac repair. In summary, BCI improves heart function and reduces abnormal cardiac remodeling by inhibiting macrophage formation and inflammation post-MI, thus providing a promising pro-drug candidate for the treatment of MI and related heart diseases. This article has an associated First Person interview with the first author of the paper.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping